Given that type I interferons and ISGs mediate tumor innate immune activation and recruit immune infiltrates (26, 27), these findings indicate that SPOP depletion enhances tumor innate immunity to suppress melanoma growth. This evidence concerns the gene SPOP and neoplasm.